S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
3 Free Stock Picks per Day (Ad)
Turkey's Erdogan declares victory in presidential runoff, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
3 Free Stock Picks per Day (Ad)
Turkey's Erdogan declares victory in presidential runoff, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
3 Free Stock Picks per Day (Ad)
Turkey's Erdogan declares victory in presidential runoff, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
3 Free Stock Picks per Day (Ad)
Turkey's Erdogan declares victory in presidential runoff, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
NYSE:CPHI

China Pharma (CPHI) Stock Forecast, Price & News

$0.35
-0.03 (-7.89%)
(As of 05/26/2023 ET)
Compare
Today's Range
$0.34
$0.40
50-Day Range
$0.29
$0.42
52-Week Range
$0.27
$4.15
Volume
451,415 shs
Average Volume
787,251 shs
Market Capitalization
$3.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CPHI stock logo

About China Pharma (NYSE:CPHI) Stock

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.

Receive CPHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter.

CPHI Stock News Headlines

"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Viva Biotech's Recent Conferences & Events Review
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Aurisco Expands Oligonucleotide Capacity and Launches New Website
China Pharma Launches N95 Mask - Quick Facts
See More Headlines
Receive CPHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter.

CPHI Company Calendar

Last Earnings
8/15/2018
Today
5/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-3,970,000.00
Pretax Margin
-40.43%

Debt

Sales & Book Value

Annual Sales
$8.10 million
Book Value
$0.48 per share

Miscellaneous

Free Float
4,986,000
Market Cap
$3.41 million
Optionable
Not Optionable
Beta
0.49

Key Executives

  • Zhi Lin Li
    Chairman, President, Chief Executive Officer & CFO













CPHI Stock - Frequently Asked Questions

How have CPHI shares performed in 2023?

China Pharma's stock was trading at $0.63 on January 1st, 2023. Since then, CPHI shares have decreased by 44.4% and is now trading at $0.35.
View the best growth stocks for 2023 here
.

Are investors shorting China Pharma?

China Pharma saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 151,900 shares, an increase of 190.4% from the April 30th total of 52,300 shares. Based on an average daily trading volume, of 353,300 shares, the days-to-cover ratio is currently 0.4 days. Approximately 1.6% of the shares of the company are sold short.
View China Pharma's Short Interest
.

How were China Pharma's earnings last quarter?

China Pharma Holdings, Inc. (NYSE:CPHI) announced its quarterly earnings results on Wednesday, August, 15th. The company reported ($0.20) earnings per share for the quarter. The firm earned $3.17 million during the quarter. China Pharma had a negative trailing twelve-month return on equity of 86.48% and a negative net margin of 40.43%.

When did China Pharma's stock split?

China Pharma's stock reverse split on the morning of Monday, March 6th 2023. The 1-10 reverse split was announced on Monday, March 6th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of China Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include iShares Silver Trust (SLV), Check-Cap (CHEK), ContraFect (CFRX), Clear Channel Outdoor (CCO), Boxlight (BOXL), Bionano Genomics (BNGO), Athersys (ATHX), Assertio (ASRT), Ampio Pharmaceuticals (AMPE) and AMC Entertainment (AMC).

What is China Pharma's stock symbol?

China Pharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "CPHI."

Who are China Pharma's major shareholders?

China Pharma's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (0.33%).

How do I buy shares of China Pharma?

Shares of CPHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is China Pharma's stock price today?

One share of CPHI stock can currently be purchased for approximately $0.35.

How much money does China Pharma make?

China Pharma (NYSE:CPHI) has a market capitalization of $3.41 million and generates $8.10 million in revenue each year.

How can I contact China Pharma?

China Pharma's mailing address is Second Floor No. 17 Jinpan Road, Haikou F4, 570216. The official website for the company is www.chinapharmaholdings.com. The company can be reached via phone at 8689866811730, via email at hps@chinapharmaholdings.com, or via fax at 86-898-6681-9024.

This page (NYSE:CPHI) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -